Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of luspatercept versus placebo in adults with non-transfusion-dependent beta-thalassemia
2015-003225-33Phase 2Unknown
- Sponsor
- Celgene Corporation
- Start
- Aug 2017
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in beta-thalassemia intermedia comparing Luspatercept with Placebo (2 arms). Primary endpoint: Hemoglobin response. Status: unknown.
02
Drugs
luspatercept
03
Conditions
beta-thalassemia intermedia
Beyond the preview
Go deeper on 2015-003225-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003225-33.